Amarin (AMRN) Says Vascepa Will Not Be in FDA's Sept. Orange Book
Tweet Send to a Friend
Amarin (Nasdaq: AMRN) filed the following 8-K with the U.S. SEC:
The U.S. Food and Drug Administration (“FDA”) typically ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
The U.S. Food and Drug Administration (“FDA”) typically ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
